Double-blind, placebo-controlled assessment of combined clonazepam with paroxetine compared with paroxetine monotherapy for generalized social anxiety disorder

Journal of Clinical Psychiatry

Volumn 65, Issue 2, 2004, Pages 244-248

  Seedat, Soraya ^a,b   Stein, Murray B ^a  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; CLONAZEPAM; PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; DRUG COMBINATION; FEMALE; HUMAN; MALE; PERSONALITY TEST; PHOBIA; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; ANTI-ANXIETY AGENTS; CLONAZEPAM; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; PAROXETINE; PERSONALITY ASSESSMENT; PHOBIC DISORDERS; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 1842834085     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Davidson JRT, Potts N, Richichi E, et al. Treatment of social phobia with clonazepam and placebo. J Clin Psychopharmacol 1993;13:423-428 (Pubitemid 24026104)
2. Schneier FR, Johnson J, Hornig CD, et al. Social phobia: comorbidity and morbidity in an epidemiologic sample. Arch Gen Psychiatry 1992;49:282-288
3. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 2-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19 (Pubitemid 24028993)
4. Magee WJ, Eaton WW, Wittchen HU, et al. Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Arch Gen Psychiatry 1996;53:159-168 (Pubitemid 26049391)
5. Blanco C, Antia SX, Liebowitz MR. Pharmacotherapy of social anxiety disorder. Biol Psychiatry 2002;51:109-120 (Pubitemid 34093799)
6. Gelernter CS, Uhde TW, Cimbolic P, et al. Cognitive behavioral and pharmacological treatment of social phobia: a controlled study. Arch Gen Psychiatry 1991;48:938-945
7. Versiani M, Nardi AE, Figuera I, et al. Double-blind placebo controlled trial with bromazepam in social phobia. J Bras Psiquiatria 1997;46:167-171 (Pubitemid 27173568)
8. Goddard AW, Brouette T, Almai A, et al. Early coadministration of clonazepam with sertraline for panic disorder. Arch Gen Psychiatry 2001;58:681-686 (Pubitemid 32651693)
9. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-P). New York, NY: Biometric Research, New York State Psychiatric Institute; 1995
10. Liebowitz MR. Social phobia. Mod Probl Pharmacopsychiatry 1987;33:141-173
11. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:218-222
12. Davidson JR, Miner CM, DeVeaugh-Geiss J, et al. The Brief Social Phobia Scale: a psychometric evaluation. Psychol Med 1997;27:161-166 (Pubitemid 27042728)
13. Beck AT, Steer RA. Beck Depression Inventory Manual. San Antonio, Tex: Psychological Corporation; 1987
14. Sheehan DV. The Anxiety Disease. New York, NY: Bantam Books; 1986
15. Rickels K, Case WG, Schweizer E, et al. Benzodiazepine dependence: management of discontinuation. Psychopharmacol Bull 1990;26:63-68 (Pubitemid 20322247)
16. Cohen J. Statistical Power Analysis for the Behavioral Sciences. New York, NY: Academic Press; 1969
17. Baldwin D, Bobes J, Stein DJ, et al, on behalf of the Paroxetine Study Group. A randomised, double-blind, placebo-controlled study of paroxetine in the treatment of social phobia/social anxiety disorder. Br J Psychiatry 1999;175:120-126
18. Allgulander C. Paroxetine treatment in social anxiety disorder: a randomised, placebo-controlled study. Acta Psychiatr Scand 1999;100:193-198 (Pubitemid 29409085)
19. Stein MB, Liebowitz MR, Lydiard RB, et al. Paroxetine treatment of generalized social phobia (social anxiety disorder). JAMA 1998;280:708-713
20. van der Linden G, Stein DJ, Balkom AJLM. The efficacy of selective serotonin reuptake inhibitors for social anxiety disorder (social phobia): a meta-analysis of randomised controlled trials. Int Clin Psychopharmacol 2000;15(suppl 2):15-23 (Pubitemid 30809843)